Salarius Pharmaceuticals, Inc.: Salarius Pharmaceuticals Announces Patient Enrollment to Resume in Investigator-initiated Phase 1/2 Clinical Trial Using Seclidemstat with Azacitidine to Treat Hematologic Cancers

Published on February 3, 2025

Seed Fund, the Google AI startup program and the NVIDIA Inception program. The company has also received QuickFire Challenge award funding

Continue reading on website
Other news

What Are The Top Five Six Data Protection Developments For 2025?

February 3, 2025
On regulation, the Government response to the Action Plan was quite muted stating that it would "set out its approach on AI regulation and

Filming Generates £4.6m for Local Economy

February 3, 2025
not be underestimated in terms of the visitor economy and inward investment. Embracing new technology will ensure that FifeScreen+TayScreen